TY - JOUR
T1 - Relationships among cerebrospinal fluid biomarkers in dementia of the Alzheimer type
AU - Csernansky, John G.
AU - Miller, J. Philip
AU - McKeel, Daniel
AU - Morris, John C.
PY - 2002/7
Y1 - 2002/7
N2 - Cerebrospinal fluid (CSF) contains proteins known to be involved in the pathogenesis of Alzheimer disease (AD), including amyloid-related proteins, tau protein and apolipoprotein E. While the CSF concentrations of these proteins have been compared in subjects with and without dementia of the Alzheimer type (DAT), they have not been simultaneously assessed in carefully staged DAT subjects and control subjects to examine correlations among them. In this study, CSF concentrations of soluble amyloid precursor protein (sAPP), two forms of β-amyloid protein (Aβtotal and Aβ1-42), tau, and apolipoprotein E were assessed in subjects with (n = 33) and without (n = 11) DAT. Direct correlations were found between CSF concentrations of sAPP and tau and Aβtotal, and between apolipoprotein E and Aβtotal within the DAT subjects and within the combined group of DAT and control subjects. A weak inverse correlation was also found between CSF concentrations of tau and Aβ1-42 within the combined group of DAT and control subjects. Moreover, increased severity of dementia was correlated with increased CSF tau concentrations and decreased sAPP and Aβtotal concentrations. Increased CSF concentrations of tau significantly discriminated DAT and control subjects, as did the ratios of tau to Aβtotal and tau to Aβ1-42.
AB - Cerebrospinal fluid (CSF) contains proteins known to be involved in the pathogenesis of Alzheimer disease (AD), including amyloid-related proteins, tau protein and apolipoprotein E. While the CSF concentrations of these proteins have been compared in subjects with and without dementia of the Alzheimer type (DAT), they have not been simultaneously assessed in carefully staged DAT subjects and control subjects to examine correlations among them. In this study, CSF concentrations of soluble amyloid precursor protein (sAPP), two forms of β-amyloid protein (Aβtotal and Aβ1-42), tau, and apolipoprotein E were assessed in subjects with (n = 33) and without (n = 11) DAT. Direct correlations were found between CSF concentrations of sAPP and tau and Aβtotal, and between apolipoprotein E and Aβtotal within the DAT subjects and within the combined group of DAT and control subjects. A weak inverse correlation was also found between CSF concentrations of tau and Aβ1-42 within the combined group of DAT and control subjects. Moreover, increased severity of dementia was correlated with increased CSF tau concentrations and decreased sAPP and Aβtotal concentrations. Increased CSF concentrations of tau significantly discriminated DAT and control subjects, as did the ratios of tau to Aβtotal and tau to Aβ1-42.
KW - Alzheimer disease
KW - Apolipoprotein E
KW - Cerebrospinal fluid
KW - Tau protein
KW - β-amyloid protein
UR - http://www.scopus.com/inward/record.url?scp=0036630457&partnerID=8YFLogxK
U2 - 10.1097/00002093-200207000-00003
DO - 10.1097/00002093-200207000-00003
M3 - Article
C2 - 12218644
AN - SCOPUS:0036630457
SN - 0893-0341
VL - 16
SP - 144
EP - 149
JO - Alzheimer disease and associated disorders
JF - Alzheimer disease and associated disorders
IS - 3
ER -